Emeritus Gustav Gaudernack
Chief Scientific Adviser.
Chief Scientific Adviser. Co-founder and inventor of Targovax peptide cancer immunotherapy technology. Professor emeritus in immunology (The Norwegian Radium Hospital). More than 40 years of research experience within the field of immunotherapy of cancer. Internationally recognized opinion leader. Author and co-author of many scientific articles and co-inventor of several patents.